REFERENCES
- Saksena N, Jozwiak R, Wang B. Molecular and biological mechanisms in the development of aids dementia complex (ADC). Bull Inst Pasteur 1998; 96: 171–187.
- Genis P, Jett M, Berton E et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: Implications for the neuropathogenesis of HIV disease. J Exp Med 1992; 176: 1703–1718.
- Nottet H, Flanagan E, Flanagan C et al. The regulation of quino-linic acid in human immunodeficiency virus-infected monocytes. J Neurovirol 1996; 2: 111–117.
- Brew B, Corbeil J, Pemberton L et al. Quinolinic acid production is related to macrophage tropic isolates. J Neurovirol 1995; 1: 369–374.
- Boiling N. Chemistry and neurochemistry of the kynurenine path-way of tryptophan metabolism. Chem Soc Rev 1995; 24: 401–412.
- Kazazi F, Mathijs J, Foley P, Cunningham AL. Variations in CD4 expression by human monocytes and macrophages and their relationships to infection with the human immunodeficiency virus. J Gen Virol 1989; 70: 2661–2672.
- Gartner S, Markovits D, Markovitz M et al. Virus isolation and identification of HTLV-III/LAV producing cells in brain tissue from a patient with AIDS. Science 1986; 233: 215–219.
- Koyanagi Y, Miles S, Mitsuyasu R et al. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 1987; 236: 819–822.
- Fear W, Kesson A, Naif H, Lynch G, Cunningham A. Differential tropism and chemokine receptor expression of human immuno-deficiency virus type 1 in neonatal monocytes, monocyte-derived macrophages, and placental macrophages. J Virol 1998; 72: 1334–1344.
- Takikawa O, Kuroiwa T, Yamazaki F, Kido R. Mechanism of interferon-γ action: characterization of indoleamine 2,3-dioxygenase in cultured human cells by interferon-γ and evaluation of the enzyme mediated tryptophan degradation in its anticellular activity. J Biol Chem 1988; 263: 2041–2048.
- Gonzalez-Scarano F, Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 1999; 22: 219–240.
- Lipton S. Neuronal injury associated with HIV-1: approaches to treatment. Ann Rev Pharmacol Toxicol 1998; 38: 159–177.
- Power C, McArthur J, Johnson R et al. Demented and non-demented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol 1994; 68: 4643–4649.
- Talley A, Dewhurst S, Perry S et al. Tumour necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bc1-2 and crmA. Mol Cell Biol 1995; 15: 2359-2366.
- Sei S, Saito K, Stewart S et al. Increased human immuno-deficiency virus (HIV) type 1 DNA content and quinolinic acid concentration in brain tissues from patients with HIV encephalopathy. J Infect Dis 1995; 172: 638–647.